Pharming Group N.V. Current Restricted Cash And Cash Equivalents
Pharming Group N.V. (PHAR) had Current Restricted Cash And Cash Equivalents of $761.00 thousand as of 2025-12-31, per its 20-F filed 2026-04-02.
Financial Statements › Notes
ifrs-full:CurrentRestrictedCashAndCashEquivalents · last filed 2026-04-02
- 2020-12-31: Current Restricted Cash And Cash Equivalents 810.00K EUR.
- 2019-12-31: Current Restricted Cash And Cash Equivalents 0.00 EUR.
EUR
| Period end | Current Restricted Cash And Cash Equivalents |
|---|---|
| 2020-12-31 | 810.00K EUR 20-F · filed 2021-04-07 |
| 2019-12-31 | 0.00 EUR 20-F · filed 2021-04-07 |
USD
| Period end | Current Restricted Cash And Cash Equivalents |
|---|---|
| 2025-12-31 | $761.00K 20-F · filed 2026-04-02 |
| 2024-12-31 | $0.00 20-F · filed 2026-04-02 |
| 2023-12-31 | $0.00 20-F · filed 2025-04-03 |
| 2022-12-31 | $213.00K 20-F · filed 2024-04-04 |
| 2021-12-31 | $227.00K 20-F · filed 2023-04-05 |
| 2020-12-31 | $995.00K 20-F · filed 2022-04-06 |
| 2019-12-31 | $0.00 20-F · filed 2022-04-06 |